ID

38195

Descrição

Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca; ODM derived from: https://clinicaltrials.gov/show/NCT02144194

Link

https://clinicaltrials.gov/show/NCT02144194

Palavras-chave

Versões (1)
  1. 26/09/2019 26/09/2019 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

26 de setembro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Breast Cancer NCT02144194

Inglês

Eligibility Breast Cancer NCT02144194

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
patients >=18 years of age
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
histologically or cytologically confirmed adenocarcinoma of the breast that is now metastatic or locally-recurrent and inoperable with curative intent
Descrição

Breast adenocarcinoma metastatic Inoperable Curative intent | Breast adenocarcinoma recurrent Locally Inoperable Curative intent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1697918
UMLS CUI [1,2]
C0205187
UMLS CUI [1,3]
C1276305
UMLS CUI [2,1]
C0861355
UMLS CUI [2,2]
C1517927
UMLS CUI [2,3]
C0205187
UMLS CUI [2,4]
C1276305
measurable and/or non-measurable disease
Descrição

Measurable Disease | Non-Measurable Lesion

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1334988
the patient's primary and/or metastatic tumor is her2 neu negative
Descrição

Primary tumor HER2/Neu Negative | Metastatic Neoplasm HER2/Neu Negative

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0677930
UMLS CUI [1,2]
C2348908
UMLS CUI [2,1]
C2939420
UMLS CUI [2,2]
C2348908
documented metastatic disease previously untreated with palliative chemotherapy
Descrição

Neoplasm Metastasis | Chemotherapy Palliative Absent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0027627
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1285530
UMLS CUI [2,3]
C0332197
adjuvant or neo-adjuvant chemotherapy (including treatment with docetaxel or any other chemotherapy) is allowed with a disease free survival of at least 6 months
Descrição

Chemotherapy, Adjuvant | Neoadjuvant Chemotherapy | docetaxel | Chemotherapy | Disease-Free Survival Duration

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0085533
UMLS CUI [2,1]
C0600558
UMLS CUI [2,2]
C3665472
UMLS CUI [3]
C0246415
UMLS CUI [4]
C0392920
UMLS CUI [5,1]
C0242793
UMLS CUI [5,2]
C0449238
no symptom or sign of brain metastasis
Descrição

Sign or Symptom Absent Metastatic malignant neoplasm to brain

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C3540840
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0220650
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
operable local recurrence
Descrição

Recurrence Local Operable

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0034897
UMLS CUI [1,2]
C0205276
UMLS CUI [1,3]
C0205188
ascites or pericardial effusion as only site of metastasis
Descrição

Ascites | Pericardial effusion | Site only Neoplasm Metastasis

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0003962
UMLS CUI [2]
C0031039
UMLS CUI [3,1]
C1515974
UMLS CUI [3,2]
C0205171
UMLS CUI [3,3]
C0027627
symptomatic peripheral neuropathy > grade 1 according to the nci common toxicity criteria
Descrição

Peripheral Neuropathy Symptomatic CTCAE Grades

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C0231220
UMLS CUI [1,3]
C1516728
radiotherapy to all areas of evaluable disease within the previous 4 weeks
Descrição

Therapeutic radiology procedure Area Evaluable Disease

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0205146
UMLS CUI [1,3]
C1516986
disease significantly affecting absorption
Descrição

Disease Affecting Absorption

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0237442
severe hepatic insufficiency
Descrição

Hepatic Insufficiency Severe

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1306571
UMLS CUI [1,2]
C0205082
patient previously treated with chemotherapy for their metastatic disease
Descrição

Prior Chemotherapy Neoplasm Metastasis

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0027627
Voltar ao início da página

Similar models

Eligibility Breast Cancer NCT02144194

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
patients >=18 years of age
boolean
C0001779 (UMLS CUI [1])
Breast adenocarcinoma metastatic Inoperable Curative intent | Breast adenocarcinoma recurrent Locally Inoperable Curative intent
Item
histologically or cytologically confirmed adenocarcinoma of the breast that is now metastatic or locally-recurrent and inoperable with curative intent
boolean
C1697918 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C1276305 (UMLS CUI [1,3])
C0861355 (UMLS CUI [2,1])
C1517927 (UMLS CUI [2,2])
C0205187 (UMLS CUI [2,3])
C1276305 (UMLS CUI [2,4])
Measurable Disease | Non-Measurable Lesion
Item
measurable and/or non-measurable disease
boolean
C1513041 (UMLS CUI [1])
C1334988 (UMLS CUI [2])
Primary tumor HER2/Neu Negative | Metastatic Neoplasm HER2/Neu Negative
Item
the patient's primary and/or metastatic tumor is her2 neu negative
boolean
C0677930 (UMLS CUI [1,1])
C2348908 (UMLS CUI [1,2])
C2939420 (UMLS CUI [2,1])
C2348908 (UMLS CUI [2,2])
Neoplasm Metastasis | Chemotherapy Palliative Absent
Item
documented metastatic disease previously untreated with palliative chemotherapy
boolean
C0027627 (UMLS CUI [1])
C0392920 (UMLS CUI [2,1])
C1285530 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Chemotherapy, Adjuvant | Neoadjuvant Chemotherapy | docetaxel | Chemotherapy | Disease-Free Survival Duration
Item
adjuvant or neo-adjuvant chemotherapy (including treatment with docetaxel or any other chemotherapy) is allowed with a disease free survival of at least 6 months
boolean
C0085533 (UMLS CUI [1])
C0600558 (UMLS CUI [2,1])
C3665472 (UMLS CUI [2,2])
C0246415 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
C0242793 (UMLS CUI [5,1])
C0449238 (UMLS CUI [5,2])
Sign or Symptom Absent Metastatic malignant neoplasm to brain
Item
no symptom or sign of brain metastasis
boolean
C3540840 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0220650 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Recurrence Local Operable
Item
operable local recurrence
boolean
C0034897 (UMLS CUI [1,1])
C0205276 (UMLS CUI [1,2])
C0205188 (UMLS CUI [1,3])
Ascites | Pericardial effusion | Site only Neoplasm Metastasis
Item
ascites or pericardial effusion as only site of metastasis
boolean
C0003962 (UMLS CUI [1])
C0031039 (UMLS CUI [2])
C1515974 (UMLS CUI [3,1])
C0205171 (UMLS CUI [3,2])
C0027627 (UMLS CUI [3,3])
Peripheral Neuropathy Symptomatic CTCAE Grades
Item
symptomatic peripheral neuropathy > grade 1 according to the nci common toxicity criteria
boolean
C0031117 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
Therapeutic radiology procedure Area Evaluable Disease
Item
radiotherapy to all areas of evaluable disease within the previous 4 weeks
boolean
C1522449 (UMLS CUI [1,1])
C0205146 (UMLS CUI [1,2])
C1516986 (UMLS CUI [1,3])
Disease Affecting Absorption
Item
disease significantly affecting absorption
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0237442 (UMLS CUI [1,3])
Hepatic Insufficiency Severe
Item
severe hepatic insufficiency
boolean
C1306571 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Prior Chemotherapy Neoplasm Metastasis
Item
patient previously treated with chemotherapy for their metastatic disease
boolean
C1514457 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial